Artemisinin resistance: current status and scenarios for containment (Q21032505)

Europe PubMed Central

title

Artemisinin resistance: current status and scenarios for containment (English)

0 references

0 references

7

Lorenz von Seidlein

Lorenz

von Seidlein

1 reference

11 July 2022

4

Chea Nguon

Chea

Nguon

1 reference

11 July 2022

Arjen M. Dondorp

1

Arjen M

Dondorp

1 reference

11 July 2022

Shunmay Yeung

2

Shunmay

Yeung

1 reference

11 July 2022

Lisa White

3

Lisa

White

1 reference

11 July 2022

Nicholas P.J. Day

5

Nicholas P J

Day

1 reference

11 July 2022

Duong Socheat

6

Duong

Nature Reviews Microbiology

Socheat

1 reference

11 July 2022

language of work or name

English

0 references

publication date

16 March 2010

0 references

published in

0 references

volume

8

0 references

issue

4

0 references

page(s)

272-80

0 references

cites work

Effectiveness of antimalarial drugs

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Impact of chloroquine resistance on malaria mortality.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Qinghaosu (Artemisinin): The Price of Success

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Artesunate combinations for treatment of malaria: meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Pharmacokinetic determinants of the window of selection for antimalarial drug resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Antimalarial drug resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

The global portfolio of new antimalarial medicines under development.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Artemisinin-resistant malaria in Asia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Artemisinin Resistance in Plasmodium falciparum Malaria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Access to artemisinin combination therapy for malaria in remote areas of Cambodia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Counterfeit artesunate antimalarials in southeast Asia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Variations in frequencies of drug resistance in Plasmodium falciparum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

The role of mathematical modelling in malaria elimination and eradication (Comment on: Can malaria be eliminated?).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Molecular surveillance of mutations in the cytochrome b gene of Plasmodium falciparum in Gabon and Ethiopia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Epidemiology of drug-resistant malaria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Mass administrations of antimalarial drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Efficacy and tolerability of initial antiretroviral therapy: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Managing drug resistant tuberculosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Primaquine revisited six decades after its discovery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Glucose-6-phosphate dehydrogenase deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Countries race to contain resistance to key antimalarial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Field evaluation of different insecticide use strategies as resistance management and control tactics for Bemisia tabaci (Hemiptera: Aleyrodidae).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Benefits of using multiple first-line therapies against malaria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Using evidence to change antimalarial drug policy in Kenya

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Pitfalls in a Discovery: The Chronicle of Chloroquine *

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRMICRO2331

31 March 2020

12 December 2020

Seventy-five years of Resochin in the fight against malaria

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Malaria: progress, perils, and prospects for eradication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Spread of chloroquine resistance in Plasmodium falciparum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

A molecular marker for chloroquine-resistant falciparum malaria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Return of chloroquine antimalarial efficacy in Malawi.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

The evolution of drug-resistant malaria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2331

Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border.

31 March 2020

1 reference

12 December 2020

Amodiaquine for treating malaria

1 reference

12 December 2020

Resistance to artemisinin derivatives along the Thai-Cambodian border

1 reference

12 December 2020

In vitro sensitivity of Plasmodium falciparum to lumefantrine in north-western Thailand

1 reference

12 December 2020

Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy.

1 reference

12 December 2020

High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia

1 reference

12 December 2020

Epidemiology of the emergence and spread of drug-resistant falciparum malaria in South-East Asia and Australasia

1 reference

12 December 2020

Localized permanent epidemics: the genesis of chloroquine resistance in Plasmodium falciparum.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRMICRO2331

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

17428

1003849904

0 references

Fatcat ID

release_2zka2e7ghncrdmhyhoybdkek7m

0 references

17428

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference